Category
QVE 1H 2024 Results Announcement
Half year results to 31 December 2023 Summary The portfolio […]
Feb 21 2024
Back in health – small cap healthcare stocks looking good for 2024
Featuring Marc Whittaker and Simon Conn
The IML small and mid cap team are excited about […]
Feb 9 2024
QVE portfolio – 2023 in review & 2024 outlook
Featuring Simon Conn & Marc Whittaker
Portfolio Managers Simon Conn and Marc Whittaker review calendar year [&hel...
Jan 10 2024
Why Orica is set for explosive(s) growth
IML portfolio managers Simon Conn and Daniel Moore discuss why […]
Dec 11 2023
September 2023 Quarterly Dividend & FY2023-24 Dividend Outlook
The Board of QV Equities Limited (the Company) has declared […]
Oct 24 2023
QVE Investment quarterly update – September 2023
Featuring Simon Conn & Marc Whittaker
Simon Conn and Marc Whittaker discuss the performance of the […]
Oct 11 2023
Keep up to date with the latest news and portfolio insights from QV Equities.
Natixis Investment Managers Australia distributes the marketing materials for QVE under an arrangement with Investors Mutual Limited (IML) AFSL 229988, as the Investment manager for, and on behalf of, QV Equities Limited ACN 169 154 858 (QVE). Your subscriber details are being collected by Natixis Investment Managers Australia, a related entity of IML. Please refer to our Privacy Policy. Natixis Investment Managers Australia Pty Limited (ABN 60 088 786 289) (AFSL No. 246830) is authorised to provide financial services to wholesale clients and to provide only general financial product advice to retail clients.